Fig. 6From: Novel nanotherapeutics for cancer immunotherapy by albumin nanoparticles functionalized with PD-1 and PD-L1 aptamersRecruitment of immunocytes to target cells in the presence or absence of PD1-NP-PDL1. Live A PD-L1-positive MDA-MB-231 cells or B PD-L1-negative A549 cells were mixed with activated PBMC in presence of either NPs or PD1-NP-PDL1, and gently washed thrice by PBS. The remaining cells were observed by phase contrast microscope. The white arrows pointed to lymphocytes in the image. Scale bar represents 20 μmBack to article page